Serious Bacterial Infections
Serious bacterial infections are a major cause of death in hospitals and healthcare settings. Bacteria can enter the body through wounds and surgery sites, ventilators and catheters, leading to pneumonia, urinary tract, abdominal and bloodstream infections. The Global Antibiotic Research and Development Partnership (GARDP) is working to develop new treatments for these serious bacterial infections, focusing on treatments for drug-resistant bacteria on the World Health Organization’s (WHO) priority pathogens list.
The country, countries or regions that benefit from this Programme.
The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.
Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.
Help with participating organisations
- Global Antibiotic Research and Development Partnership
Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.
A comparison across financial years of forecast budget and spend to date on the Programme.